Ethical Consideration
Because this research includes human subjects, ethical approval was
taken from the Ministry of Health and the local ethical commitee. All
patient were informed about the study and informed consent was obtained.
RESULTS:
A total of 42 hospitalized patients who were confirmed positive for
COVID-19 and had a temporal computed tomography (CT) scans, paranasal CT
axial scans or cranial CT scans were included to this study.
The mean age was 45,61 (standard deviation ± 19.60; min–max 20–83
years). Of the 42 patients, 26 (61.9%) were male and 16 (38.1%) were
female. Patients were divided into two groups according to their chest
CT findings. Group 1 had specific chest CT findings and included 26
patients, group 2 had no findings in chest CT and included 16 patients.
There were no difference in the female/male proportion between groups
(p: 0.636). There was no difference between the groups for comorbid
diseases (Table 1) and onset symptoms of disease (Table 2). No obvious
mastoid air cells and middle ear cavity involvement was observed in any
of the patients. Temporal imaging findings were compared according to
our grading system and there were no difference between the groups
(p=0,50) (Table 3).
DISCUSSION:
SARS-CoV-2 virus found in high concentrations in nose and nasopharynx.
Nasopharynx has close relation with mastoid cells and middle ear. Airway
mucosa is involved in COVID-19. Middle ear, eustachian tube and mastoid
cells are covered by airway mucosa which is involved in COVID-19.
Because of these findings ear might be contaminated but there is no
evidence.1,12,13
It is known that coronaviruses has role in acute otitis media and upper
respiratory tract infections. Effusion often seen in acute otitis media
and upper respiratory tract infections. This effusion can be seen in
radiological examination of the middle ear and mastiod cells. There is a
unknown about SARS-CoV-2’s middle ear involvement. Virus might cause
otitis media like other coronaviruses and this can be seen in
radiological imaging.6.13,14
Evaluating hearing loss pathogenesis of COVID-19 has getting attention
and needs more studies and evidence. Middle ear and mastoid cavity may
be an important route of infection. Virus may effect middle ear, inner
ear or mastoid cells and cause hearing loss which may be detected by
temporal bone imaging. But there is no study about temporal bone imaging
of COVID-19.
Untill now there is no specific treatment for COVID-19, so hand hygiene,
social distancing, quarantine and wearing face masks are the main points
of the preventing the spread of the disease. 15,16,17
COVID-19 pneumonia has typical radiological signs in chest CT like
unilateral or bilateral ground-glass opacities and consolidation with or
without vascular enlargement, interlobular septal thickening, and air
bronchogram sign.18
In our study we found no specific involment in temporal bone. No typical
CT findings and interestingly no effusion in mastoid cells or middle
ear. All patients had normal healthy temporal CT. There were no
difference between two groups according to grading with or without
typical signs of COVID-19 in chest CT.
Our study is the first study which investigate the temporal CT in
COVID-19. The signs of acute otitis and/or effusion and typical CT
findings in temporal bone were investigated.
Limitations of our study were retrospective design, small number of the
study groups and lack of hearing test of the patients. Because the
COVID-19 is very contagious we could not design a prospective study,
which performs temporal bone tomography and hearing test together to all
of the patients.
We examined the tympanic membranes of the all patients but we did not
perform hearing test and tympanometric test to patients. After
evaluating the mastoid cells, middle ear and inner ear temporal bone
findings we found that the virus has no effect on temporal bone with or
without chest CT findings. It can be suggested that hearing loss in
COVID-19 is not because of the effusion in ear, acute otitis or any
involment that can be diagnosed via temporal CT with these findings.
Further studies with larger populations, detailed hearing tests,
cochlear and inner ear evaluation will be useful to evaluate the
etiology of hearing loss in COVID-19.
CONCLUSİON:
There was no middle ear or mastoid involment also no effusion seen in
COVID-19. According to our findings SARS-CoV-2 doesn’t cause any
temporal bone radiological changes.
References:
- Zou L, Ruan F, Huang M, et al. SARS-CoV-2 viral load in upper
respiratory specimens of infected patients. N Engl J Med .
2020;382(12):1177-1179. doi:10.1056/NEJMc2001737.
- van Doremalen N, Bushmaker T, Morris DH, et al. Aerosol and surface
stability of SARS-CoV-2 as compared with SARS-CoV-1 [published
online March 17, 2020]. N Engl J Med . doi:10.1056/
NEJMc2004973.
- Givi B et al. Safety Recommendations for Evaluation and Surgery of the
Head and Neck During the COVID-19 Pandemic. JAMA Otolaryngol Head Neck
Surg. 2020 Mar 31. doi: 10.1001/jamaoto.2020.0780. Online ahead of
print.PMID: 32232423.
- Chen JX, Workman AD, Chari DA, et al. Demonstration and mitigation of
aerosol and particle dispersion during mastoidectomy relevant to the
COVID-19 era [published online ahead of print, 2020 May
8]. Otol Neurotol . 2020;10.1097/MAO.0000000000002765.
doi:10.1097/MAO.0000000000002765.
- Heikkinen T, Thint M, Chonmaitree T.Prevalence of various respiratory
viruses in the middle ear during acute otitis media. N Engl J
Med . 1999;340(4):260-264. doi:10.1056/ NEJM199901283400402.
- Pitkäranta A, Virolainen A, Jero J, Arruda E, Hayden FG. Detection of
rhinovirus, respiratory syncytial virus, and coronavirus infections in
acute otitis media by reverse transcriptase polymerase chain reaction.Pediatrics . 1998;102(2, pt 1):291-295.
doi:10.1542/peds.102.2.291.
- 7 Brennan TE, Saadia-Redleaf MI.
Occult middle ear and
mastoid fluid in acute otitis externa.
Laryngoscope. 2012 Sep;122(9):2067-70. doi: 10.1002/lary.23414. Epub
2012 Jul 2.PMID: 22753076.
- Stuart
P Adler. Congenital Cytomegalovirus Screening. Pediatr Infect Dis
J. 2005 Dec;24(12):1105-6. doi: 10.1097/00006454-200512000-00016.
- H
al
Muhaimeed, S
M Zakzouk. Hearing Loss and Herpes Simplex. J Trop Pediatr. 1997
Feb;43(1):20-4. doi: 10.1093/tropej/43.1.20.
- S
S
Chandrasekhar , P
E
Connelly, S
S
Brahmbhatt, C
S
Shah, P
C
Kloser, S
Baredes. Otologic and Audiologic Evaluation of Human Immunodeficiency
Virus-Infected Patients. Am J Otolaryngol. Jan-Feb 2000;21(1):1-9.
doi: 10.1016/s0196-0709(00)80117-9.
- MWM
Mustafa. Audiological Profile of Asymptomatic Covid-19 PCR-positive
Cases. Am J Otolaryngol. 2020 Apr 10;102483. doi:
10.1016/j.amjoto.2020.102483. Online ahead of print.
- Cetinkaya EA. COVID-19 Pandemic and Otologic Surgery [published
online ahead of print, 2020 May 28]. J Craniofac Surg .
2020;10.1097/SCS.0000000000006694. doi:10.1097/SCS.0000000000006694.
- Saadi RA, Bann DV, Patel VA, Goldenberg D, May J, Isildak H. A
Commentary on Safety Precautions for Otologic Surgery during the
COVID-19 Pandemic. Otolaryngol Head Neck Surg .
2020;162(6):797‐799. doi:10.1177/019459982091974.
- Chen N, Hou Q, Cui Z, et al. Effect of otitis media with effusion and
its clinical intervention on the development of mastoid in
children. Acta Otolaryngol . 2014;134(5):481‐484.
doi:10.3109/00016489.2013.878810.
- Guner R, Hasanoglu I, Aktas F. COVID-19: Prevention and control
measures in community. Turk J Med Sci (2020) 50: 571-577.
doi:10.3906/sag-2004-146.
- Cheng VC, Wong SC, Chuang VW et al.
The
role of community-wide wearing of face mask for control of coronavirus
disease 2019 (COVID-19) epidemic due to SARS-CoV-2. Infect. 2020 Apr
23:S0163-4453(20)30235-8. doi: 10.1016/j.jinf.2020.04.024. Online
ahead of print.
- Şimşek Yavuz S, Ünal S. Antiviral treatment of COVID-19. Turk J
Med Sci . 2020;50(SI-1):611‐619. Published 2020 Apr 21.
doi:10.3906/sag-2004-145.
- Ufuk F, Savaş R. Chest CT features of the novel coronavirus disease
(COVID-19) [published online ahead of print, 2020 May
12]. Turk J Med Sci . 2020;10.3906/sag-2004-331.
doi:10.3906/sag-2004-331.